Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 111 Lymphoid 90 Myeloid 69 Plasma cell 47 Classical hematology 21 Other neoplasm 5 Genitourinary 3 Dermatologic 3 CNS 3 Thoracic 2 Sarcoma 2 Other 1 Gastrointestinal 1 Breast 1

Conditions

Obesity 365 Neoplasms 138 Mucositis 112 Breast Neoplasms 98 Sexual Dysfunction, Physiological 91 Overweight 87 Polycystic Ovary Syndrome 86 Dyspnea 57 Constipation 51 Motor Activity 48 Head and Neck Neoplasms 42 Prostatic Neoplasms 38 Weight Loss 34 Diabetes Mellitus 31 Colorectal Neoplasms 30 Pain 28 Opioid-Induced Constipation 28 Stomatitis 25 Lung Neoplasms 25 Endometrial Neoplasms 24 Depression 24 Diabetes Mellitus, Type 2 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Obesity, Morbid 19 Multiple Endocrine Neoplasia Type 1 19 Insulin Resistance 19 Cardiovascular Diseases 19 Anxiety Disorders 19 Sexual Dysfunctions, Psychological 16 Metabolic Syndrome 16

Interventions

Surveys and Questionnaires 1 Sugars 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡